M. KARAHAN Et Al. , "Malignancy In Adrenal Incidentalomas: Are Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Significant?," Eastern Journal of Medicine , vol.29, no.3, pp.386-390, 2024
KARAHAN, M. Et Al. 2024. Malignancy In Adrenal Incidentalomas: Are Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Significant?. Eastern Journal of Medicine , vol.29, no.3 , 386-390.
KARAHAN, M., OKUT, G., MÜLKÜT, F., SAĞLAM, K., & SÜMER, F., (2024). Malignancy In Adrenal Incidentalomas: Are Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Significant?. Eastern Journal of Medicine , vol.29, no.3, 386-390.
KARAHAN, Mehmet Et Al. "Malignancy In Adrenal Incidentalomas: Are Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Significant?," Eastern Journal of Medicine , vol.29, no.3, 386-390, 2024
KARAHAN, Mehmet Et Al. "Malignancy In Adrenal Incidentalomas: Are Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Significant?." Eastern Journal of Medicine , vol.29, no.3, pp.386-390, 2024
KARAHAN, M. Et Al. (2024) . "Malignancy In Adrenal Incidentalomas: Are Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Significant?." Eastern Journal of Medicine , vol.29, no.3, pp.386-390.
@article{article, author={Mehmet KARAHAN Et Al. }, title={Malignancy In Adrenal Incidentalomas: Are Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Significant?}, journal={Eastern Journal of Medicine}, year=2024, pages={386-390} }